Paper
0
Cyclosporine before PCI in Patients with Acute Myocardial Infarction
Authors
Thien Cung,Olivier Morel
Guillaume Cayla,Gilles Rioufol,Sandrine Lecour,Denis Angoulvant,Eric Bonnefoy‐Cudraz,Patrice Guérin,Meyer Elbaz,Nicolas Delarche,Pierre Coste,Gérald Vanzetto,M Metge,Jean‐François Aupetit,Bernard Jouve,Pascal Motreff,Christophe Tron,Lila Bouadma,Philippe Steg,Yves Cottin,Grégoire Rangé,J. Clerc,Marc Claeys,Patrick Coussement,Fabrice Prunier,Frédéric Moulin,Olivier Roth,Martine Gilard,Philippe Dúbois,Paul Barragan,Christophe Caussin,Patrice Colin,F. Poli,Marie‐Claude Morice,Omar Ider,Jean‐Luc Dubois‐Randé,Thierry Unterseeh,Hervé Breton,T Béard,Didier Carrié,Gilles Grollier,V. Malquarti,Patrick Staat,Arnaud Sudre,Eskil Elmér,Magnus Hansson,Cyrille Bergerot,Inesse Boussaha,Claire Jossan,Geneviève Dérumeaux,Nathan Mewton,Michel Ovize
+50 authors
,Grégoire RangePublished
Aug 30, 2015
Show more
Save
Tip0
TipSave
Abstract
Experimental and clinical evidence suggests that cyclosporine may attenuate reperfusion injury and reduce myocardial infarct size. We aimed to test whether cyclosporine would improve clinical outcomes and prevent adverse left ventricular remodeling.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.